FDA approves first drug intended to slow cognitive decline caused by Alzheimer’s disease

It is the first drug cleared that is designed to alter the course of the disease by slowing the deterioration of brain function — not just to ease symptoms.

Read the full post at Health
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive